Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› HIV-1-infection
Clinical trial register · Italy

HIV-1-infection Trials in Italy, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 7 Roma 4 Foggia 2 Brescia 2 Pavia 2
Narrow the registerReset
Recruitment status
Phase
Site location
Milan7 Roma4 Foggia2 Brescia2 Pavia2
All 19 locations
Target enrolment
to

HIV-1-infection trials in Italy

10 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Active, closed
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
NCT06532656HIV-1-infection
Gilead Sciences
Phase 2/3
75
Milan, Roma
2024-11-20
Recruiting
Prevention ICONA Dedicated Ensemble
NCT07186244PrEP, PrEP Adherence Monitoring, HIV, HIV -1 Infection
Fondazione ICONA
Observational
5,000
Chieti, Pescara, Bari, Foggia, Potenza, Caserta, Naples, Bologna
2024-09-09
Active, closed
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
NCT06333808HIV-1-infection
Gilead Sciences
Phase 3
577
Brescia, Foggia, Milan, Monza, Pavia, Roma
2024-03-25
Active, closed
The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events
NCT05421286HIV-1-infection, Inflammation, AIDS
Copenhagen University Hospital, Rigshospitalet
Observational
991
Milan
2022-09-28
Active, closed
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
NCT05502341HIV-1-infection
Gilead Sciences
Phase 2/3
689
Milan, Modena, Roma, Torino
2022-08-16
Recruiting
HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia
NCT06127290HIV-1-infection
Euresist Network GEIE
Observational
200
Siena
2021-12-01
Active, closed
Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)
NCT04776252HIV-1 Infection
Merck Sharp & Dohme LLC
Phase 3
2,000
Rome, Milan, Pavia
2021-09-15
Recruiting
Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.
NCT04098315HIV-1-infection, Multi-Antiviral Resistance
Castagna Antonella
Observational
300
Milan
2017-12-14
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 8 October 2026. https://priyalifescience.com/clinical-trials-italy/condition/hiv-1-infection

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition HIV-1-infection.

How many HIV-1-infection trials are recruiting in Italy?

3 of the 10 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (HIV-1-infection), 10 studies
PhaseStudiesRecruitingShare
Observational5350%
Phase 2/33030%
Phase 32020%

Most active sponsors

Lead sponsors with the most studies (HIV-1-infection)
Lead sponsorStudiesRecruiting
Gilead Sciences40
Castagna Antonella11
Copenhagen University Hospital, Rigshospitalet10
Ente Ospedaliero Ospedali Galliera10
Euresist Network GEIE11
Fondazione ICONA11
Merck Sharp & Dohme LLC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.